InstaCare Extends MD@Hand & MD@Work Mobile EMR/EHR Technology to Smart Pad Systems
LOS ANGELES, March 3, 2011 /PRNewswire/ — InstaCare Corp. (OTC Bulletin Board: ISCR), a leading provider of prescription drugs, home testing products for the chronically ill, a leading fulfillment provider of direct to patient diabetes programs, and a leading developer of revolutionary patent pending cell phone centric e-health products and technologies, today announced that it has migrated its recently patent pending MD@Hand and MD@Work technologies for application to the highly touted Smart Pad computers.
The Company announced that it has received inquiries from two traditional healthcare companies and a major smart phone company with expressions of interest, or formal plans. Management is evaluating options with each of the potential partners and has initially agreed to migrate its MD@Hand and MD@Work technologies to the Apple iPad, Motorola Xoom, Blackberry Playbook and Samsung Galaxy tablet (pad) computer systems. The company estimates that the technology migration will be complete within 60 days.
Keith Berman, CFO and Secretary of InstaCare commented, “We have received inquiry from two traditional healthcare service companies and a large smart phone provider. Each of these organizations has voiced unique needs and has determined that to catch up to the rapidly evolving EMR/EHR standards as well as offering the highly exciting e-detailing service to pharmaceutical companies, they have to move quickly. We continue to believe that our best available alternative would be to form partnerships to market our technology to new and alternative markets.”
Mr. Berman continued, “We remain totally committed to monetizing our game-changing and recently patented technologies. The market reaction, including inquiries and proposals from traditional healthcare service companies and a smart phone provider has reinforced our confidence that we have not only the ideal product for the new healthcare marketplace, but perhaps our cell phone-centric solution is the only completed and ready-to-deploy product that will work in an environment where mandates are the order of the day.”
For more information about InstaCare Corp., Pharma Tech Solutions, Inc. MD@Hand, MD@Work and/or its revolutionary Genstrip please visit the InstaCare web site www.instacare.net or www.pharmatechdirect.com or call the company at (805) 446-2973.
Forward-looking statements are statements made herein which do not address historical facts and, therefore could be interpreted to be forward-looking statements. We can give no assurance that the expectations indicated by such forward-looking statements will be realized. There may be other risks and circumstances that we are unable to predict. When used in this release, words such as “believes,” “expects,” “forecasts,” “intends,” “projects,” “plans,” “anticipates,” “estimates” and similar expressions are intended to identify forward-looking statements, although there may be certain statements not accompanied by such expressions. All forward-looking statements are intended to be covered by the safe harbor created by Section 21E of the Securities Exchange Act of 1934. Such statements are subject to factors that could cause actual results to differ materially from anticipated results. The forward-looking statements included in this press release represent our views as of March 3, 2011. We anticipate that subsequent events and developments will cause our views to change.
Contact: Keith Berman, Secretary and CFO firstname.lastname@example.org 2660 Townsgate Road Suite 300 Westlake Village, CA 91361 Ph : 805-446-1973 Fax: 805-446-1983
SOURCE InstaCare Corp.